We know exercise is good for health, but there isn’t a one-size-fits-all prescription when it comes to individual needs. Everyone is different in terms of how their bodies fight diseases and respond to therapies. The physicians and scientists at AdventHealth are working on some of the biggest problems in health care, including uncovering the mystifying effects of exercise.
In this episode of the Inspiring Wholeness podcast, Dr. Steven Smith, senior vice president and chief scientific officer at AdventHealth and Bret Goodpaster, Ph.D., senior scientific director at AdventHealth’s Translational Research Institute, discuss partnering with the National Institute of Health on a 10-year study titled Molecular Transducers of Physical Activity Consortium (MoTrPAC).
The goal of the research is to discover more about why the body breaks; how physical activity can improve brain health, protect the heart, prevent diabetes, influence cancer and promote other health benefits; and why people’s bodies respond differently to exercise.
Listen now and subscribe so you never miss a new episode.
12 items. To interact with these items, press Control-Option-Shift-Right Arrow. These items are in a slider. To advance slider forward, press Shift-Command-Right Arrow. To advance slider backward, press Shift-Command-Left Arrow.
News
AdventHealth Research Institute and NESTRE Health & Performance Announce Collaboration to Advance Neurocognitive Health and Performance Through Cognitive Training
With an aging population and increases in the prevalence of neurological conditions like Alzheimer’s disease and dementia, physicians and patients alike continue to seek new tools and approaches to...
News
Recent Study on How Physical Activity May Boost Neurocognition in Late Adulthood Featured in the Medical Journal Age and Ageing
In a new article published in the medical journal Age and Ageing, AdventHealth Research Institute’s Dr. Audrey Collins shares the results of a recent study evaluating the impact of exercise on...
News
AdventHealth Among First in U.S. to Offer IDP023-2-101 Clinical Trial for Patients with Progressive Multiple Sclerosis
The AdventHealth Neuroscience Institute is the first in Florida and one of the first in the country to begin recruiting patients with primary progressive or non-active secondary progressive multiple...
